The National Turkey Federation supports import permit to improve treatment of the contagious respiratory disease.

Boehringer Ingelheim and Eli Lilly have launched phase 3 clinical trials to evaluate the glycemic efficacy and safety of linagliptin in patients with type 2 diabetes with prevalent albuminuria ...

Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear ... Alongside the merger, investors committed $10.3 million in a private placement, with the money originally ...

Boehringer Ingelheim’s weight-loss drug candidate ... dysfunction-associated steatotic liver disease (MASLD), which in turn has been rebranded from non-alcoholic fatty liver disease (NAFLD).

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

The heritage of Boehringer Ingelheim in developing ... leading to widening of the airways, which, in turn, improves expiratory flow 3. Since obstruction of the airways and associated symptoms ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well ... meaning that we are looking to turn cold tumors into hot tumors. And we do that through cancer ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...